PCSK9 and dengue disease: In addition, findings also indicate that PCSK9 is a host factor for DENV in target cells resident in hypoxic microenvironments and that inhibiting PCSK9 rather than just HMGCoA reductase could be a useful approach to fill the therapeutic void for dengue treatment [54].